Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or... – Including perfusion; composition therefor
Patent
1997-07-18
2000-06-27
Saucier, Sandra E.
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
Including perfusion; composition therefor
435 11, 435 2, 604 49, 604 52, A01N 102, A61M 3100
Patent
active
060805382
ABSTRACT:
Aqueous solutions comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salts of calcium, sodium and magnesium, and a dissolved organic salt of sodium are disclosed. The solutions are effective substitutes for blood and may be used to preserve the biological integrity of the organs of a mammalian donor organism as shown by superior anatomical integrity of cryopreserved organs and tissues of subjects perfused with the solution. The solutions may be used for maintaining a partially or substantially completely exsanguinated subject at normal temperatures and at temperatures substantially below those normally maintained by a mammal and may be used in conjunction with hypobaric environments to maintain such partially or completed exsanguinated subjects alive without infusing blood back into the subject.
REFERENCES:
patent: Re34077 (1992-09-01), Segall et al.
patent: 3937821 (1976-02-01), Irikura et al.
patent: 3949098 (1976-04-01), Bangert
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4216205 (1980-08-01), Radowitz
patent: 4663166 (1987-05-01), Veech
patent: 4769318 (1988-09-01), Hamasaki et al.
patent: 4908350 (1990-03-01), Kramer et al.
patent: 4923442 (1990-05-01), Segall et al.
patent: 4927806 (1990-05-01), Kramer et al.
patent: 5082831 (1992-01-01), Leaf et al.
patent: 5084377 (1992-01-01), Rowan et al.
patent: 5120719 (1992-06-01), Iwamoto et al.
patent: 5130230 (1992-07-01), Segall et al.
patent: 5171526 (1992-12-01), Wong et al.
patent: 5374624 (1994-12-01), Segel
patent: 5407428 (1995-04-01), Segall et al.
patent: 5416078 (1995-05-01), Hedlund et al.
patent: 5571801 (1996-11-01), Segall et al.
patent: 5702880 (1997-12-01), Segall et al.
patent: 5747071 (1998-05-01), Segall et al.
Collins, G.M., (1977) "Hypothermic Kidney Storage," Transplantation Proceedings IX: 1529-1534.
Kallerhoff, M. et al., (1985) "Effects of Preservation Conditions and Temperature on Tissue Acidification in Canine Kidneys," Transplantation 39: 485-489.
Messmer, K. "Characteristics, Effects and Side-Effects of Plasma Substitutes," Bodensee Symposium on Microcirculation (Hammersen and Messmer, eds.) Karger, N.Y., p. 51-70 (1989).
Spahn, D.R., et al., (1994) "Cardiovascular and Coronary Physiology of Acute Isovolemic Hemodilution: A Review of Nonoxygen-Carrying and Oxygen-Carrying Solutions," Anesth. Analg. 78: 1000-1021.
Wagner, B.K.J. and D'Amelio, L.F., (1993) "Pharmacologic and Clinical Considerations in Selecting Crystalloid, Colloidal, and Oxygen-Carrying Resuscitation Fluids, Part 1," Clinical Pharmacy 12: 335-346.
Boerema et al., (1972) "Life Without Blood," J. Cardiovasc. Surger. 13: 133-146.
Fischbach, F., (1988) "Chemistry Studies: Potassium (K)," A Manual of Laboratory Diagnostic Tests, Third Edition, Chapter 6, pp. 254-257.
Belzer, F.O. et al., (1985) "Combination Perfusion-Cold Storage for Optimum Cadaver Kidney Function and Utilization," Transplantation 39 : 118-121.
Bishop, M.C. and Ross, B.D., (1978) "Evaluation of Hypertonic Citrate Flushing Solution for Kidney Preservation Using the Isolated Perfused Rat Kidney," Transplantation 25 : 235-239.
Ross, H. et al., (1976) " 72-Hr Canine Kidney Preservation Without Continuous Perfusion," Transplantation 21 : 498-510.
Wall, W.J., (1977) "Simple Hypothermic Preservation for Transporting Human Livers Long Distances for Transplantation," Transplantation 23: 210-216.
ATCC Catalogue of Bacteria and Bacteriophages, (1992) p. 486, Medium 1590.
Lehninger, A. (1982) " Digestion, Transport, and the Integration of Metabolism," Principles of Biochemistry Chapter 24, Part III, pp. 705-713.
Fisher, J.H. et al., (1985) Flush Solution 2, A New Concept for One-to-Three-Day Hypothermic Renal Storage Preservation, Transplantation 39: 122-126.
Sprung, J. et al., (1991) "Effects of Acute Hypothermia and -Adrenergic receptor Blockade on Serum Potassium Concentration in Rats," Critical care Medicine 19: 1545-1551.
Bailes et al., (1990) " The Use of Ultra-profound Hypothermia in a Totally Exsanguinated and Blood-Substituted Canine Model. I," Cyrobiology 27: 622-623.
Elrifai et al., (1990) " The Use of Ultra-profound Hypothermia in a Totally Exsanguinated and Blood-Substituted Canine Model. II," Cyrobiology 27: 622-623.
Smith, A., (1956) " Studies on Golden Hamsters During Cooling to and Rewarming from Body Temperatures Below 0.degree.C.," Proceedings of the Royal Society 145: 391-442.
Leavitt, et al. (1990) " Surivival from Prolonged cardiac Arrest in Totally Exsanguinated Hypothermic Dogs," Abstracts: Federation ofAmerican Societies for Experimental Biology Part 2, 4048.
Segall et al., (1987) " Ice-Cold Bloodless Dogs Revived Using Protocol Developed in Hamsters," Abstracts: Federation of American Societies for Experimental Biology 5959.
Segall et al., (1991) "Animal Models in Ice-Cold Bloodless Medicne," Abstracts: The FASEB Journal Part I, 147.
Sternberg, et al., (1990) " Interventive Gerontology, Cloning and Cryonics," Biomedical Advances in Aging Chpt. 19:207-219.
Sternberg, et al., (1991) "Partly-Frozen Overnight, Thawed Hamsters' Hearts Beat," 1991 FASEB Abstract Form.
Storey, K.B. and Storey, J.M., (1990) " Frozen and Alive," Scientific American 263(6): 92-97.
Waitz et al., (1991) "Hamsters Live After Hours of Bloodless Hyperbaric O .sub.2," Abstracts: The FASEB Journal Part II, 4375.
Bishop et al., (1978) "Evaluation of Hypertonic Citrate Flushing Solution for Kidney Preservation Using the Isolated Perfused Rat Kidney," Transplantation 25:235.
"10% LMD in 5% Dextrose Injection . . . ," Product Information Sheet, Abbott Laboratories, North Chicago, IL.
"6% Dextran 70 in 5% Dextrose Injection . . . ," Product Information Sheet, 91987) Abbott Laboratories, North Chicago, IL.
Guyton A.C., Textbook of Medical Physiology (1991) W.B.Saunders Co., pp. 277-280.
Dewacher et al., "In vivo rhelogic studies of plasma substitutes", Annales Francaises D'Anesthesie et de Reanimation 11 (5) : 516-25 (1992).
Smiley, "The use of hetastarch for plamsa expansion", Problems in Veterinary Medicine 4 (4) : 652-67 (1992).
Levin et al., "Comparative evaluation of the effects of crystalloid solutions containing sodium lactate and sodium succinate on the hemodynamic indicators in different types of hemorrhage", Gematologiia I Transfuziologiia 36 (2) : 25-8 (1991).
DiStazio et al., "Effect of ATP-MgCI2-Glucose Administration During Hemorrhagic Shock on Cardiovascular Function, Metabolism, and Survival", Advances in Shock Research 3 : 153-66, 1980.
Wang et al., "ATP-MgCI2 Restores the Depressed Cardiac Output Following Trauma and Severe Hemorrhage Even in the Absence of Blood Resuscitation", Circulatory Shock 36 : 277-283, 1992.
Segall Judith M.
Segall Paul E.
Sternberg Hal
Waitz Harold D.
BioTime, Inc.
Field Bret
Saucier Sandra E.
LandOfFree
Plasma like solution and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasma like solution and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasma like solution and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1782991